ARO-DIMERPA

· Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARO-DIMERPA, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia [Phase 1, Phase 2]